Abiopharma

🔍 Fentress Andrew (Director)

Company: ACRES Commercial Realty Corp. (ACR)

Report Date: 2026-08-06

Detailed Transactions and Holdings:

• Acquired 988,453 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,029,855.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 892,213 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 892,213.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: H | nature_of_ownership: By minor children | shares_owned_after: 26,316.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-06 | Code: H | nature_of_ownership: By parents | shares_owned_after: 18,483.00

Footnotes:

• F1: Pursuant to the Agreement and Plan of Merger, dated April 29, 2026, between ACRES Commercial Realty Corp. (the "Company") and ACRES Holdings Sub LLC, a subsidiary of the Company, on the one hand, and ACRES Capital Corp ("ACC") and ACRES Capital, LLC, a subsidiary of ACC and the external manager of the Company, on the other hand, (i) each outstanding share of common stock, $0.0001 par value per share, of ACC converted into the right to receive 2.61882 shares of common stock, $0.001 par value per share, of the Company.
• F2: The Reporting Person's spouse is the controlling member of a limited liability company, of which the Reporting Person is a minority member.